Imvivabio
2 known investors
A clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases, targeting off-the-shelf and scalable treatments to improve patient access.
Founders & leadership
LH
Lu HanChief Executive Officer
JR
Jiangtao RenChief Scientific Officer
YN
Yajin NiChief Technology Officer
Investors · 2
Frequently asked questions
- What does Imvivabio do?
- A clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases, targeting off-the-shelf and scalable treatments to improve patient access.
- Who are Imvivabio's investors?
- Imvivabio's investors include Decheng Capital, 7G BioVentures.